Print Page

Medicine recalls

 
Taiwan: Recall of 保孕威凍晶注射劑75國際單位 BRAVELLE 75 I.U. Powder and Solvent for solution for Injection
 
In Hong Kong, Bravelle Powder and Solvent for Inj 75IU (HK-58374) is a pharmaceutical product registered by Ferring Pharmaceuticals Ltd (Ferring), and is a prescription-only medicine. Related news has been issued previosuly by the MHRA and Health Canada, which was posted on the Drug Office website on 23 and 26 October 2015 respectively. So far, the Department of Health (DH) has not received adverse drug reaction case related to the product. As confirmed with Ferring, the affected batches in all the above places have not been imported into Hong Kong. As previously reported, Ferring has quarantined the exisitng stock on hand as a precautionary measure, while awaiting its headquarter's investigation result. DH will continue to follow up on the incident and remain vigilant on the latest news by other overseas drug regulatory authorities, and will take follow-up action timely .

Please refer to the following Chinese website for details: http://www.drugoffice.gov.hk/eps/news/../25335.html

Ends/ Friday, November 06, 2015
Issued at HKT 14:00
 
Related Information:
Canada: BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots ... Posted 2015-10-26
The United Kingdom: Company-led recall: Bravelle 75IU powder for solution for in... Posted 2015-10-23
 
back